Associations of relative fat mass with metabolic dysfunction–associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017–2023

Key Points

• Relative fat mass is linked to increased risk of metabolic dysfunction—associated steatotic liver disease and liver fibrosis.
• A significant association was found, with higher relative fat mass correlating to liver health issues.
• Observational analysis from the NHANES data collected between 2017 and 2023 reveals critical insights.
• This highlights the need for further research on how relative fat mass impacts liver health among adults.